首页> 外文期刊>Journal of clinical gastroenterology >Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials.
【24h】

Tolerability and patient acceptance of sodium phosphate tablets compared with 4-L PEG solution in colon cleansing: combined results of 2 identically designed, randomized, controlled, parallel group, multicenter phase 3 trials.

机译:与4-L PEG溶液在结肠清洗中相比,磷酸钠片剂的耐受性和患者接受度:2项相同设计,随机,对照,平行组,多中心3期试验的合并结果。

获取原文
获取原文并翻译 | 示例
           

摘要

GOALS: Evaluate patient tolerance and acceptance of a sodium phosphate (NaP) tablet purgative compared with a 4-L polyethylene glycol (PEG) solution. BACKGROUND: Characteristics and side effects of bowel purgatives deter patients from undergoing screening colonoscopy. Published data demonstrated comparable bowel cleansing with NaP tablets and a 4-L PEG solution in 2 phase for 3 studies. This report presents data on patient tolerability and acceptance. STUDY: Two identically designed, randomized, investigator-blinded, and multicenter trials were performed. Tolerability and patient acceptance were based on purgative regimen compliance, incidence of gastrointestinal adverse events, and patient responses to questionnaires. RESULTS: Eight hundred forty-five patients were assessed (420 and 425 in the tablet and PEG solution groups, respectively). Patient compliance with the tablet regimen was greater: 94% of patients took all the tablets compared with 57% completing the PEG solution regimen (P<0.0001). Nausea, vomiting, and bloating occurred significantly less often in patients taking NaP tablets (P<0.0001). Among patients taking tablets, 88.4% rated them "easy" or "slightly difficult" to take, compared with 60.6% of patients taking the PEG solution. The preparation's taste was rated "barely tolerable" or "not tolerable" by 1% of patients treated with NaP tablets and 23.6% treated with PEG solution. Drinking the required volume of clear liquid for the tablet or PEG preparation was rated "easy" or "slightly difficult" by 92.2% and 66.9% of patients, respectively. Almost all (90.7%) patients taking the tablets indicated they would take the same preparation in the future, compared with 67.1% of patients taking the PEG solution (P<0.0001 for each comparison). CONCLUSIONS: Tolerability and patient acceptance of a NaP tablet purgative were superior to 4-L PEG solution.
机译:目标:与4-L聚乙二醇(PEG)溶液相比,评估患者的耐受性和对磷酸钠(NaP)泻药的接受程度。背景:肠道泻药的特征和副作用阻止患者接受结肠镜检查。已发表的数据表明,用NaP片剂和4-L PEG溶液分两阶段进行了3次研究,具有类似的肠清洗效果。该报告提供了有关患者耐受性和接受性的数据。研究:进行了两项相同设计的随机,研究者盲和多中心试验。耐受性和患者接受度基于泻药方案依从性,胃肠道不良事件的发生率以及患者对问卷的反应。结果:八百四十五名患者进行了评估(片剂和PEG溶液组分别为420和425)。患者对片剂方案的依从性更高:94%的患者服用了所有片剂,而完成PEG溶液方案的患者为57%(P <0.0001)。服用NaP片剂的患者中恶心,呕吐和腹胀的发生率显着降低(P <0.0001)。在服用片剂的患者中,有88.4%的人将其评定为“容易”或“稍微困难”,而服用PEG溶液的患者为60.6%。用NaP片剂治疗的患者中有1%,用PEG溶液治疗的患者中有23.6%将制剂的味道评为“几乎不能耐受”或“不能耐受”。分别将92.2%和66.9%的患者喝了所需量的片剂或PEG制剂所需的透明液体评为“容易”或“稍微困难”。几乎所有服用片剂的患者(90.7%)都表示他们将来会服用相同的制剂,而服用PEG溶液的患者中有67.1%的患者(每次比较P <0.0001)。结论:NaP片泻药的耐受性和患者接受度优于4-L PEG溶液。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号